|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
Arbor Vita Corporation Presents New Data on Cancer Diagnostic at EUrogin
11/14/2008 9:05:44 AM
NICE, FRANCE--(Marketwire - November 14, 2008) - Arbor Vita Corporation (AVC), a privately held biopharmaceutical company, presented new data today on its rapid, point-of-care prototype HPV test with a high positive predictive value for cervical cancer and pre-cancer. Targeted for use throughout the developing world, this diagnostic test is being developed in partnership with PATH. The presentation, "Development of a Rapid Diagnostic Test for Cervical Pre-Cancer and Cancer," was given during the "Molecular Markers" session at Eurogin 2008, an international conference providing a comprehensive overview of current scientific advances in the field of cervical cancer control, including early detection.
|
|
|
|
|
|
|
|
|
|
|